What is the recommended dosage of Keflex (cephalexin) for adults and children for different infection severities, including adjustments for renal impairment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Keflex Dosage

For adults, Keflex is dosed at 250-500 mg every 6 hours (or 500 mg every 12 hours for uncomplicated infections), with a maximum of 4 g daily; for children, the standard dose is 25-50 mg/kg/day divided into 4 doses, with higher doses (75-100 mg/kg/day) for severe infections like otitis media. 1

Adult Dosing

Standard infections:

  • 250 mg every 6 hours for mild infections
  • 500 mg every 12 hours for streptococcal pharyngitis, uncomplicated skin infections, and uncomplicated cystitis (patients >15 years)
  • 500 mg every 6 hours for more severe infections or less susceptible organisms
  • Maximum: 4 g daily (if higher doses needed, consider parenteral cephalosporins) 1

Specific indications from guidelines:

  • Skin/soft tissue infections (MSSA): 500 mg four times daily 2, 3, 4
  • Methicillin-susceptible S. aureus pneumonia (children): 75-100 mg/kg/day in 3-4 doses 5, 6
  • UTI duration: 7-14 days 1

Pediatric Dosing

Standard dose: 25-50 mg/kg/day divided every 6 hours (four times daily) 1

Condition-specific dosing:

  • Streptococcal pharyngitis and skin infections: May divide total daily dose every 12 hours (twice daily) for patients >1 year 1
  • Otitis media: 75-100 mg/kg/day in 4 divided doses 1
  • Severe infections: Double the standard dose 1
  • UTI (infants >28 days): 50-100 mg/kg/day in 4 doses 7
  • Bone and joint infections: Recent evidence supports 45 mg/kg/dose (maximum 1.5 g) three times daily as effective and well-tolerated 8

Important: For β-hemolytic streptococcal infections, continue therapy for at least 10 days 1

Renal Impairment Adjustments

Dosing must be reduced when creatinine clearance <30 mL/min 9, 10. The elimination rate correlates directly with creatinine clearance (Ke = 0.0766 + 0.0060 × CrCl) 9.

Specific adjustments:

  • Normal renal function: Serum half-life ~1 hour; 64% urinary recovery in 6 hours 9
  • Anephric patients: Serum half-life increases to ~8.5 hours 9
  • Hemodialysis: Removes 58% of serum cephalexin over 6 hours 11
  • Practical approach: Reduce dose proportionally to reduced creatinine clearance 10

Clinical Considerations

Absorption and timing:

  • Cephalexin is completely absorbed from the upper intestine (not stomach) 10
  • Can be given without regard to meals, though food may improve GI tolerability 1
  • Peak levels occur at 2 hours in normal patients 9

Common pitfalls:

  • Children have greater body water turnover and may require higher per-kilogram doses than adults 10
  • Delayed absorption can occur in anephric patients (peak levels at 6-12 hours in some cases) 11
  • The standard four-times-daily dosing creates adherence challenges; twice-daily dosing may be reasonable for UTIs 12 and three-times-daily for bone/joint infections 8

Safety profile:

  • Low protein binding and no metabolism in the body 10
  • Does not penetrate host cells, contributing to low side effect incidence 10
  • Minimal disruption of lower bowel flora due to upper intestinal absorption 10
  • Most common adverse effect is diarrhea; neutropenia can occur but is usually mild 8

References

Research

The pharmacology of cephalexin.

Postgraduate medical journal, 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.